We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Astellas Pharma Inc. (TSE: 4503) and Fujitsu Limited (TSE: 6702) today announced that they have reached an information-system outsourcing agreement on October 28.
The shortage of antiretroviral (ARV) drugs in Ghana is a direct result of the country's heavy reliance on the benevolence of international donors in national HIV/AIDS treatment programmes, according to domestic AIDS charities.
A free HIV/AIDS treatment centre has been opened recently in Tijuana, Mexico, after a collaboration between Mexican NGO Agencia Familiar Binacional (AFABI) and the US-based AIDS Healthcare Foundation (AHF).
The outgoing Polish government has made a number of recommendations regarding reform of the medical reimbursement scheme in the country, in a bid to make the system more efficient and cut expenditure.
Output in Singapore's biomedical manufacturing sector is soaring,
according to official data, increasing 146.9% in September compared to the same period last year.
Orchid Chemicals & Pharmaceuticals Ltd has raised $75 million by way of global depository receipts (GDRs) and $37.5 million through the issue of convertible bonds.
Amgen, the world's largest biotechnology company, today announced that Kepivance(TM) (palifermin) has received regulatory approval in the European Union (EU).
Novartis AG said the European Commission granted marketing authorisation in all 25 EU member states for Xolair, an injectable treatment for severe allergic asthma.
French biotechnology company NicOx said on Thursday it had signed an agreement giving Canadian-based Topigen the North American rights to develop and market its experimental NCX 1020 treatment for inflamed lungs.